According to IMARC Group latest report titled “Neurorehabilitation Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, offers a comprehensive analysis of the industry, which comprises insights on neurorehabilitation devices market size. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The global neurorehabilitation devices market size reached US$ 1.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.1 Billion by 2028, exhibiting a growth rate (CAGR) of 10.5% during 2023-2028.
Neurorehabilitation devices are technologically advanced medical tools designed to aid in the recovery of individuals suffering from nervous system diseases or injuries. These devices employ cutting-edge technology to stimulate neuroplasticity, the brain’s capacity to generate new neural connections, thereby aiding in the recovery of motor and cognitive abilities. These devices include a diverse range of equipment, such as wearable devices, neuro-robotic systems, brain-computer interfaces, and non-invasive brain stimulators. They are commonly utilized in hospitals, rehabilitation centers, and home healthcare settings. These devices serve as an essential therapeutic tool in addressing numerous neurological disorders such as stroke, spinal cord injury, traumatic brain injury, Parkinson’s disease, and multiple sclerosis. With the increasing incidences of neurological conditions coupled with advancements in neuroscientific research, the demand for effective neurorehabilitation devices is gaining traction.
Get a Sample Copy of this Report: https://www.imarcgroup.com/neurorehabilitation-devices-market/requestsample
Market Trends:
The escalating prevalence of neurological disorders is driving the global market. Moreover, ongoing advancements in neuroscientific research and technology are leading to the development of more sophisticated, user-friendly, and efficient devices, which is further catalyzing the market. Besides, the advent of AI and machine learning technologies are introducing a new era of innovation in the neurorehabilitation devices market. These technologies enable personalized rehabilitation processes by adjusting to the unique needs and progress of each patient, thereby enhancing therapeutic outcomes. The neurorehabilitation devices market is also bolstered by increasing healthcare expenditures and the growing inclination of health systems towards patient-centric, outcome-based treatments. Besides, the increasing awareness about the availability of these is further impacting the market.
View Full Report with TOC & List of Figure: https://www.imarcgroup.com/neurorehabilitation-devices-market
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
- Biometrics Ltd, Bioness Inc.
- Bionik Laboratories Corp
- BioXtreme Ltd.
- Boston Scientific Corporation
- Ectron Ltd
- Ekso Bionics
- Hocoma AG (DIH International Limited)
- Kinestica
- Kinova Inc.
- Medtronic plc
- Saebo Inc
- Tyromotion GmbH
Neurorehabilitation Devices Market Segmentation:
Our report has categorized the market based on region, product type, application and end use.
Breakup by Product Type:
- Neurorobotic Devices
- Wearable Devices
- Non-Invasive Stimulators
- Brain-Computer Interface
Breakup by Application:
- Stroke
- Multiple Sclerosis
- Parkinson’s Disease
- Cerebral Palsy
- Others
Breakup by End User:
- Hospitals and Clinics
- Cognitive Care Centers
- Others
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023-2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe:- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800